Published in Medical Letter on the CDC and FDA, February 22nd, 2009
In patients with hereditary antithrombin deficiency, Thrombate III prevents thromboembolism in high risk situations such as surgery, childbirth, and acute thromboembolism. It is pasteurized to inactivate viruses and purified to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.